Covered recipient · General Payments record
STACY SCHILZ
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2021–2024
$1,032.94
- Reported across 49 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $375.10 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $63.97 | 3 |
| ABBVIE INC. | $60.39 | 3 |
| Lundbeck LLC | $41.87 | 2 |
| Otsuka America Pharmaceutical, Inc. | $38.91 | 2 |
| ARGENX US, INC. | $27.90 | 1 |
| Genentech USA, Inc. | $25.55 | 1 |
| Janssen Pharmaceuticals, Inc | $24.64 | 1 |
| Biogen, Inc. | $24.63 | 1 |
| Neos Therapeutics, LP | $24.53 | 1 |
| PFIZER INC. | $21.41 | 1 |
| Corium, Inc. | $21.30 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $18.42 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108154693 | CMS |
| ABBVIE INC. | $28.21 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108154695 | CMS |
| ABBVIE INC. | $13.76 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108154697 | CMS |
| ARGENX US, INC. | $27.90 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142149900 | CMS |
| Biogen, Inc. | $24.63 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104870884 | CMS |
| Corium, LLC | $21.30 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100181428 | CMS |
| Genentech USA, Inc. | $25.55 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133189189 | CMS |
| Janssen Pharmaceuticals, Inc | $24.64 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078008124 | CMS |
| Lilly USA, LLC | $25.60 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135866976 | CMS |
| Lilly USA, LLC | $20.89 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135943990 | CMS |
| Lilly USA, LLC | $17.48 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135890878 | CMS |
| Lundbeck LLC | $22.40 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146087088 | CMS |
| Lundbeck LLC | $19.47 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146087090 | CMS |
| Neos Therapeutics, LP | $24.53 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1082671547 | CMS |
| Otsuka America Pharmaceutical, Inc. | $20.55 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119180662 | CMS |
| Otsuka America Pharmaceutical, Inc. | $18.36 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119180664 | CMS |
| PFIZER INC. | $21.41 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131577428 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.